IDEXXs

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of fiscal 2025. Third-quarter revenue grew 13% year-over-year to $1.11 billion; sales rose 12% on an organic basis CAG Diagnostics recurring revenue increased 11% on a reported basis and 10% on an organic basis Livestock, Poultry, … Read more

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024. Fourth-quarter revenues increased 6% annually to $954.3 million; organic revenue growth was 6% Net income attributable to shareholders moved up to $216.1 million in Q4 from $194.5 million a year earlier On a … Read more